context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
Under our Executive Long-Term Incentive Compensation Plan (Executive Plan), share-based awards may be issued to key employees through a broad range of methods, including non-qualified and incentive stock options, performance shares, performance units, restricted stock, restricted stock units, stock appreciation rights ... | text | 0.5 | sharesItemType | text: <entity> 0.5 </entity> <entity type> sharesItemType </entity type> <context> Under our Executive Long-Term Incentive Compensation Plan (Executive Plan), share-based awards may be issued to key employees through a broad range of methods, including non-qualified and incentive stock options, performance shares, perf... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
Under our ESPP, eligible employees may purchase ALLETE common stock at a 5 percent discount from the market price; we are not required to apply fair value accounting to these awards as the discount is not greater than 5 percent. | text | 5 | percentItemType | text: <entity> 5 </entity> <entity type> percentItemType </entity type> <context> Under our ESPP, eligible employees may purchase ALLETE common stock at a 5 percent discount from the market price; we are not required to apply fair value accounting to these awards as the discount is not greater than 5 percent. </context... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate |
As of December 31, 2024, the total unrecognized compensation cost for the performance share awards and restricted stock units not yet recognized in our Consolidated Statement of Income was $ 3.3 million and $ 1.1 million, respectively. These amounts are expected to be recognized over a weighted-average period of 1.7 ye... | text | 3.3 | monetaryItemType | text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the total unrecognized compensation cost for the performance share awards and restricted stock units not yet recognized in our Consolidated Statement of Income was $ 3.3 million and $ 1.1 million, respectively.... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
As of December 31, 2024, the total unrecognized compensation cost for the performance share awards and restricted stock units not yet recognized in our Consolidated Statement of Income was $ 3.3 million and $ 1.1 million, respectively. These amounts are expected to be recognized over a weighted-average period of 1.7 ye... | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the total unrecognized compensation cost for the performance share awards and restricted stock units not yet recognized in our Consolidated Statement of Income was $ 3.3 million and $ 1.1 million, respectively.... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
There were approximately 65,300 performance shares granted in January 2025 for the three -year performance period ending in 2027. The ultimate issuance is contingent upon the attainment of certain goals of ALLETE during the performance periods. The grant date fair value of the performance shares granted was $ 4.6 milli... | text | 65300 | sharesItemType | text: <entity> 65300 </entity> <entity type> sharesItemType </entity type> <context> There were approximately 65,300 performance shares granted in January 2025 for the three -year performance period ending in 2027. The ultimate issuance is contingent upon the attainment of certain goals of ALLETE during the performance... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
There were approximately 65,300 performance shares granted in January 2025 for the three -year performance period ending in 2027. The ultimate issuance is contingent upon the attainment of certain goals of ALLETE during the performance periods. The grant date fair value of the performance shares granted was $ 4.6 milli... | text | 14200 | sharesItemType | text: <entity> 14200 </entity> <entity type> sharesItemType </entity type> <context> There were approximately 65,300 performance shares granted in January 2025 for the three -year performance period ending in 2027. The ultimate issuance is contingent upon the attainment of certain goals of ALLETE during the performance... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
There were approximately 65,300 performance shares granted in January 2025 for the three -year performance period ending in 2027. The ultimate issuance is contingent upon the attainment of certain goals of ALLETE during the performance periods. The grant date fair value of the performance shares granted was $ 4.6 milli... | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> There were approximately 65,300 performance shares granted in January 2025 for the three -year performance period ending in 2027. The ultimate issuance is contingent upon the attainment of certain goals of ALLETE during the performance... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
There were approximately 25,900 restricted stock units granted in January 2025 for the vesting period ending in 2027. The grant date fair value of the restricted stock units granted was $ 1.7 million. There were approximately 12,300 restricted stock units awarded in February 2025. The grant date fair value of the share... | text | 25900 | sharesItemType | text: <entity> 25900 </entity> <entity type> sharesItemType </entity type> <context> There were approximately 25,900 restricted stock units granted in January 2025 for the vesting period ending in 2027. The grant date fair value of the restricted stock units granted was $ 1.7 million. There were approximately 12,300 re... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
There were approximately 25,900 restricted stock units granted in January 2025 for the vesting period ending in 2027. The grant date fair value of the restricted stock units granted was $ 1.7 million. There were approximately 12,300 restricted stock units awarded in February 2025. The grant date fair value of the share... | text | 12300 | sharesItemType | text: <entity> 12300 </entity> <entity type> sharesItemType </entity type> <context> There were approximately 25,900 restricted stock units granted in January 2025 for the vesting period ending in 2027. The grant date fair value of the restricted stock units granted was $ 1.7 million. There were approximately 12,300 re... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
There were approximately 25,900 restricted stock units granted in January 2025 for the vesting period ending in 2027. The grant date fair value of the restricted stock units granted was $ 1.7 million. There were approximately 12,300 restricted stock units awarded in February 2025. The grant date fair value of the share... | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> There were approximately 25,900 restricted stock units granted in January 2025 for the vesting period ending in 2027. The grant date fair value of the restricted stock units granted was $ 1.7 million. There were approximately 12,300 re... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
Regulated Operations includes three operating segments which consist of our regulated utilities, Minnesota Power and SWL&P, as well as our investment in ATC. ALLETE Clean Energy is our business focused on developing, acquiring and operating clean and renewable energy projects. We also present Corporate and Other which ... | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> Regulated Operations includes three operating segments which consist of our regulated utilities, Minnesota Power and SWL&P, as well as our investment in ATC. ALLETE Clean Energy is our business focused on developing, acquiring and ope... | us-gaap:NumberOfOperatingSegments |
(d) Net Income in 2022 includes a $ 8.3 million after-tax expense as a result of purchase price accounting related to projects under development at the time of acquisition and $ 2.7 million after-tax of transaction costs related to the acquisition of New Energy. | text | 2.7 | monetaryItemType | text: <entity> 2.7 </entity> <entity type> monetaryItemType </entity type> <context> (d) Net Income in 2022 includes a $ 8.3 million after-tax expense as a result of purchase price accounting related to projects under development at the time of acquisition and $ 2.7 million after-tax of transaction costs related to ... | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
(e) Net income in 2024 includes transaction expenses of $ 22.6 million after-tax related to the Merger. (See Note 15. Agreement and Plan of Merger.) | text | 22.6 | monetaryItemType | text: <entity> 22.6 </entity> <entity type> monetaryItemType </entity type> <context> (e) Net income in 2024 includes transaction expenses of $ 22.6 million after-tax related to the Merger. (See Note 15. Agreement and Plan of Merger.) </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
Subject to the terms and conditions set forth in the Merger Agreement, which has been unanimously approved by the board of directors of ALLETE and approved and adopted by the shareholders of ALLETE, at the effective time of the Merger (Effective Time), each share of common stock, without par value, of ALLETE (ALLETE co... | text | 67.00 | perShareItemType | text: <entity> 67.00 </entity> <entity type> perShareItemType </entity type> <context> Subject to the terms and conditions set forth in the Merger Agreement, which has been unanimously approved by the board of directors of ALLETE and approved and adopted by the shareholders of ALLETE, at the effective time of the Merge... | us-gaap:BusinessAcquisitionSharePrice |
Subject to the terms and conditions set forth in the Merger Agreement, which has been unanimously approved by the board of directors of ALLETE and approved and adopted by the shareholders of ALLETE, at the effective time of the Merger (Effective Time), each share of common stock, without par value, of ALLETE (ALLETE co... | text | 3.9 | monetaryItemType | text: <entity> 3.9 </entity> <entity type> monetaryItemType </entity type> <context> Subject to the terms and conditions set forth in the Merger Agreement, which has been unanimously approved by the board of directors of ALLETE and approved and adopted by the shareholders of ALLETE, at the effective time of the Merger ... | us-gaap:BusinessCombinationConsiderationTransferred1 |
The Merger Agreement contains certain termination rights for ALLETE and Alloy Parent, which were described in a Current Report of Form 8-K filed by ALLETE on May 6, 2024. In the Merger Agreement, among other things, ALLETE has agreed, subject to certain exceptions, to, and to cause each of its subsidiaries to conduct i... | text | 300 | monetaryItemType | text: <entity> 300 </entity> <entity type> monetaryItemType </entity type> <context> The Merger Agreement contains certain termination rights for ALLETE and Alloy Parent, which were described in a Current Report of Form 8-K filed by ALLETE on May 6, 2024. In the Merger Agreement, among other things, ALLETE has agreed, ... | us-gaap:BusinessCombinationContingentConsiderationAsset |
These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities in the normal course of business. The Company is an early-stage growth company and has generated negative cash flows from operating activities since inception. ... | text | 244.4 | monetaryItemType | text: <entity> 244.4 </entity> <entity type> monetaryItemType </entity type> <context> These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities in the normal course of business. The Company is an early-stage growth co... | us-gaap:StockholdersEquity |
These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities in the normal course of business. The Company is an early-stage growth company and has generated negative cash flows from operating activities since inception. ... | text | 9.2 | monetaryItemType | text: <entity> 9.2 </entity> <entity type> monetaryItemType </entity type> <context> These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities in the normal course of business. The Company is an early-stage growth comp... | us-gaap:CashEquivalentsAtCarryingValue |
These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities in the normal course of business. The Company is an early-stage growth company and has generated negative cash flows from operating activities since inception. ... | text | 210.5 | monetaryItemType | text: <entity> 210.5 </entity> <entity type> monetaryItemType </entity type> <context> These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities in the normal course of business. The Company is an early-stage growth co... | us-gaap:Investments |
Total charges and expenses related to the Plan of $ 3.0 million and $ 11.5 million for the | text | 3.0 | monetaryItemType | text: <entity> 3.0 </entity> <entity type> monetaryItemType </entity type> <context> Total charges and expenses related to the Plan of $ 3.0 million and $ 11.5 million for the </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
Total charges and expenses related to the Plan of $ 3.0 million and $ 11.5 million for the | text | 11.5 | monetaryItemType | text: <entity> 11.5 </entity> <entity type> monetaryItemType </entity type> <context> Total charges and expenses related to the Plan of $ 3.0 million and $ 11.5 million for the </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
and nil consisting of property and equipment in connection with the Plan at their fair value less costs to sell at December 31, 2024 and 2023, respectively. We used fair value hierarchy Level III inputs including comparable assets, adjusted for condition, and recorded charges of | text | nil | monetaryItemType | text: <entity> nil </entity> <entity type> monetaryItemType </entity type> <context> and nil consisting of property and equipment in connection with the Plan at their fair value less costs to sell at December 31, 2024 and 2023, respectively. We used fair value hierarchy Level III inputs including comparable assets, adj... | us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup |
and nil included in exit and termination costs in the consolidated statements of operations f | text | nil | monetaryItemType | text: <entity> nil </entity> <entity type> monetaryItemType </entity type> <context> and nil included in exit and termination costs in the consolidated statements of operations f </context> | us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf |
We recorded net benefits for recoveries related to asset sales of $ 2.8 million and nil included in exit and termination costs in the consolidated statements of operations | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> We recorded net benefits for recoveries related to asset sales of $ 2.8 million and nil included in exit and termination costs in the consolidated statements of operations </context> | us-gaap:GainLossOnDispositionOfAssets1 |
We recorded net benefits for recoveries related to asset sales of $ 2.8 million and nil included in exit and termination costs in the consolidated statements of operations | text | nil | monetaryItemType | text: <entity> nil </entity> <entity type> monetaryItemType </entity type> <context> We recorded net benefits for recoveries related to asset sales of $ 2.8 million and nil included in exit and termination costs in the consolidated statements of operations </context> | us-gaap:GainLossOnDispositionOfAssets1 |
The Company provided a supplier with a letter of credit for $ 7.9 million in the fourth quarter of 2023 to secure the performance of the Company, backed by a restricted cash deposit to pay any draws on the letter of credit by the supplier. The Company was released from this letter of credit in the first quarter of 2024... | text | 7.9 | monetaryItemType | text: <entity> 7.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company provided a supplier with a letter of credit for $ 7.9 million in the fourth quarter of 2023 to secure the performance of the Company, backed by a restricted cash deposit to pay any draws on the letter of credit by the suppl... | us-gaap:LettersOfCreditOutstandingAmount |
The Company has provided its corporate headquarters lessor with a letter of credit for $ 0.7 million to secure the performance of the Company’s lease obligations, backed by a restricted cash deposit to pay any draws on the letter of credit by the lessor. | text | 0.7 | monetaryItemType | text: <entity> 0.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company has provided its corporate headquarters lessor with a letter of credit for $ 0.7 million to secure the performance of the Company’s lease obligations, backed by a restricted cash deposit to pay any draws on the letter of cr... | us-gaap:LettersOfCreditOutstandingAmount |
Accounts receivable are stated at a gross invoice amount, net of an allowance for doubtful accounts. The allowance for doubtful accounts is maintained at a level considered adequate to provide for potential account losses on the balance based on the Company’s evaluation of the anticipated impact of current economic con... | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> Accounts receivable are stated at a gross invoice amount, net of an allowance for doubtful accounts. The allowance for doubtful accounts is maintained at a level considered adequate to provide for potential account losses on the balanc... | us-gaap:AccountsReceivableGross |
Accounts receivable are stated at a gross invoice amount, net of an allowance for doubtful accounts. The allowance for doubtful accounts is maintained at a level considered adequate to provide for potential account losses on the balance based on the Company’s evaluation of the anticipated impact of current economic con... | text | nil | monetaryItemType | text: <entity> nil </entity> <entity type> monetaryItemType </entity type> <context> Accounts receivable are stated at a gross invoice amount, net of an allowance for doubtful accounts. The allowance for doubtful accounts is maintained at a level considered adequate to provide for potential account losses on the balanc... | us-gaap:AccountsReceivableGross |
The Company was performing under two contracts as both a prime and subcontractor to the United States government to provide R&D services. The larger of these two contracts was modified and accounted for as a new contract in the quarter ending December 31, 2024. These contracts were not accounted for as revenue prior to... | text | 16.0 | monetaryItemType | text: <entity> 16.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company was performing under two contracts as both a prime and subcontractor to the United States government to provide R&D services. The larger of these two contracts was modified and accounted for as a new contract in the quarte... | us-gaap:GovernmentAssistanceAwardAmount |
The Company was performing under two contracts as both a prime and subcontractor to the United States government to provide R&D services. The larger of these two contracts was modified and accounted for as a new contract in the quarter ending December 31, 2024. These contracts were not accounted for as revenue prior to... | text | 15.7 | monetaryItemType | text: <entity> 15.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company was performing under two contracts as both a prime and subcontractor to the United States government to provide R&D services. The larger of these two contracts was modified and accounted for as a new contract in the quarte... | us-gaap:GovernmentAssistanceAwardAmount |
Marketing, promotional and advertising costs are expensed as incurred and are included as an element of selling, general and administrative expense in the consolidated statement of operations. Marketing, promotional and advertising costs were $ 0.1 million and $ 1.3 million for the years ended December 31, 2024 and 202... | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> Marketing, promotional and advertising costs are expensed as incurred and are included as an element of selling, general and administrative expense in the consolidated statement of operations. Marketing, promotional and advertising cos... | us-gaap:MarketingAndAdvertisingExpense |
Marketing, promotional and advertising costs are expensed as incurred and are included as an element of selling, general and administrative expense in the consolidated statement of operations. Marketing, promotional and advertising costs were $ 0.1 million and $ 1.3 million for the years ended December 31, 2024 and 202... | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> Marketing, promotional and advertising costs are expensed as incurred and are included as an element of selling, general and administrative expense in the consolidated statement of operations. Marketing, promotional and advertising cos... | us-gaap:MarketingAndAdvertisingExpense |
The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $ 0.0001 per share. The Company’s Board is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, option or other special rights and any qualifications, limitations and restr... | text | 10000000 | sharesItemType | text: <entity> 10000000 </entity> <entity type> sharesItemType </entity type> <context> The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $ 0.0001 per share. The Company’s Board is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, par... | us-gaap:PreferredStockSharesAuthorized |
The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $ 0.0001 per share. The Company’s Board is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, option or other special rights and any qualifications, limitations and restr... | text | 0.0001 | perShareItemType | text: <entity> 0.0001 </entity> <entity type> perShareItemType </entity type> <context> The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $ 0.0001 per share. The Company’s Board is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, par... | us-gaap:PreferredStockParOrStatedValuePerShare |
On May 21, 2024, the Company’s shareholders approved a new long-term incentive award plan (the “2024 Plan”). The 2024 Plan is administered by the Board and the compensation committee. The selection of participants, allotment of shares, determination of price and other conditions are approved by the Board and the compen... | text | 8000000 | sharesItemType | text: <entity> 8000000 </entity> <entity type> sharesItemType </entity type> <context> On May 21, 2024, the Company’s shareholders approved a new long-term incentive award plan (the “2024 Plan”). The 2024 Plan is administered by the Board and the compensation committee. The selection of participants, allotment of share... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
Share-based compensation expense under the 2024 Plan for the years ended December 31, 2024 and 2023 was nil . The fair value of RSUs that vested during the years ended December 31, 2024 and 2023 was nil . There was $ 0.4 million of unrecognized compensation expense related to the 2024 Plan at December 31, 2024, which i... | text | 0.4 | monetaryItemType | text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> Share-based compensation expense under the 2024 Plan for the years ended December 31, 2024 and 2023 was nil . The fair value of RSUs that vested during the years ended December 31, 2024 and 2023 was nil . There was $ 0.4 million of unr... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
On October 1, 2020, the Company’s shareholders approved a new long-term incentive award plan (the “2020 Plan”) in connection with the business combination agreement and plan of reorganization, pursuant to which SHLL Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Tortoise Acquisition Corp., a Del... | text | 12200000 | sharesItemType | text: <entity> 12200000 </entity> <entity type> sharesItemType </entity type> <context> On October 1, 2020, the Company’s shareholders approved a new long-term incentive award plan (the “2020 Plan”) in connection with the business combination agreement and plan of reorganization, pursuant to which SHLL Merger Sub Inc.,... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
We granted 2.7 million market-conditioned restricted stock units in 2024 that vested between February 13, 2025 and December 31, 2026 contingent upon achieving underlying closing stock price thresholds. Through December 31, 2024, there was achievement of underlying closing stock price thresholds on 100 % of these awards... | text | 2.7 | sharesItemType | text: <entity> 2.7 </entity> <entity type> sharesItemType </entity type> <context> We granted 2.7 million market-conditioned restricted stock units in 2024 that vested between February 13, 2025 and December 31, 2026 contingent upon achieving underlying closing stock price thresholds. Through December 31, 2024, there wa... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
We granted 2.7 million market-conditioned restricted stock units in 2024 that vested between February 13, 2025 and December 31, 2026 contingent upon achieving underlying closing stock price thresholds. Through December 31, 2024, there was achievement of underlying closing stock price thresholds on 100 % of these awards... | text | 0.83 | perShareItemType | text: <entity> 0.83 </entity> <entity type> perShareItemType </entity type> <context> We granted 2.7 million market-conditioned restricted stock units in 2024 that vested between February 13, 2025 and December 31, 2026 contingent upon achieving underlying closing stock price thresholds. Through December 31, 2024, there... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue |
We granted 2.7 million market-conditioned restricted stock units in 2024 that vested between February 13, 2025 and December 31, 2026 contingent upon achieving underlying closing stock price thresholds. Through December 31, 2024, there was achievement of underlying closing stock price thresholds on 100 % of these awards... | text | 90 | percentItemType | text: <entity> 90 </entity> <entity type> percentItemType </entity type> <context> We granted 2.7 million market-conditioned restricted stock units in 2024 that vested between February 13, 2025 and December 31, 2026 contingent upon achieving underlying closing stock price thresholds. Through December 31, 2024, there wa... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate |
We granted 2.7 million market-conditioned restricted stock units in 2024 that vested between February 13, 2025 and December 31, 2026 contingent upon achieving underlying closing stock price thresholds. Through December 31, 2024, there was achievement of underlying closing stock price thresholds on 100 % of these awards... | text | 4.35 | percentItemType | text: <entity> 4.35 </entity> <entity type> percentItemType </entity type> <context> We granted 2.7 million market-conditioned restricted stock units in 2024 that vested between February 13, 2025 and December 31, 2026 contingent upon achieving underlying closing stock price thresholds. Through December 31, 2024, there ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate |
Excludes 1,336,667 shares underlying RSU awards with performance conditions, which have not been accounted for because no accounting grant date has been established. | text | 1336667 | sharesItemType | text: <entity> 1336667 </entity> <entity type> sharesItemType </entity type> <context> Excludes 1,336,667 shares underlying RSU awards with performance conditions, which have not been accounted for because no accounting grant date has been established. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber |
Excludes 25,000 shares underlying RSU awards with performance conditions, which have not been accounted for because no accounting grant date has been established. | text | 25000 | sharesItemType | text: <entity> 25000 </entity> <entity type> sharesItemType </entity type> <context> Excludes 25,000 shares underlying RSU awards with performance conditions, which have not been accounted for because no accounting grant date has been established. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross |
Excludes 59,584 shares underlying RSU awards with performance conditions, which have not been accounted for because no accounting grant date has been established. | text | 59584 | sharesItemType | text: <entity> 59584 </entity> <entity type> sharesItemType </entity type> <context> Excludes 59,584 shares underlying RSU awards with performance conditions, which have not been accounted for because no accounting grant date has been established. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod |
Excludes 633,750 shares underlying RSU awards with performance conditions, which have not been accounted for because no accounting grant date has been established. These excluded shares were not granted during the year ended December 31, 2024. | text | 633750 | sharesItemType | text: <entity> 633750 </entity> <entity type> sharesItemType </entity type> <context> Excludes 633,750 shares underlying RSU awards with performance conditions, which have not been accounted for because no accounting grant date has been established. These excluded shares were not granted during the year ended December ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber |
Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023 was $ 2.3 million and $ 2.8 million, respectively. There was $ 4.6 million of unreco... | text | 4.6 | monetaryItemType | text: <entity> 4.6 </entity> <entity type> monetaryItemType </entity type> <context> Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023... | us-gaap:EmployeeBenefitsAndShareBasedCompensation |
Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023 was $ 2.3 million and $ 2.8 million, respectively. There was $ 4.6 million of unreco... | text | 6.2 | monetaryItemType | text: <entity> 6.2 </entity> <entity type> monetaryItemType </entity type> <context> Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023... | us-gaap:EmployeeBenefitsAndShareBasedCompensation |
Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023 was $ 2.3 million and $ 2.8 million, respectively. There was $ 4.6 million of unreco... | text | 2.3 | monetaryItemType | text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023 was $ 2.3 million and $ 2.8 million, respectively. There was $ 4.6 million of unreco... | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023 was $ 2.3 million and $ 2.8 million, respectively. There was $ 4.6 million of unreco... | text | 4.6 | monetaryItemType | text: <entity> 4.6 </entity> <entity type> monetaryItemType </entity type> <context> Share-based compensation expense under the 2020 Plan for the years ended December 31, 2024 and 2023 was $ 4.6 million and $ 6.2 million, respectively. The fair value of RSUs that vested during the years ended December 31, 2024 and 2023... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
The Hyliion Inc. 2016 Equity Incentive Plan (the “2016 Plan”), as amended in August 2017 and approved by the Board, permitted the granting of various awards including stock options (including both nonqualified options and incentive options), stock appreciation rights (“SARs”), stock awards, phantom stock units, perform... | text | No | sharesItemType | text: <entity> No </entity> <entity type> sharesItemType </entity type> <context> The Hyliion Inc. 2016 Equity Incentive Plan (the “2016 Plan”), as amended in August 2017 and approved by the Board, permitted the granting of various awards including stock options (including both nonqualified options and incentive option... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to exclude from the intrinsic value computation. The intrinsic value of options exercised... | text | 0.5 | monetaryItemType | text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to e... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue |
At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to exclude from the intrinsic value computation. The intrinsic value of options exercised... | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to e... | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 |
At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to exclude from the intrinsic value computation. The intrinsic value of options exercised... | text | 0.4 | monetaryItemType | text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to e... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue |
At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to exclude from the intrinsic value computation. The intrinsic value of options exercised... | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to e... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue |
At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to exclude from the intrinsic value computation. The intrinsic value of options exercised... | text | nil | monetaryItemType | text: <entity> nil </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to e... | us-gaap:EmployeeBenefitsAndShareBasedCompensation |
At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to exclude from the intrinsic value computation. The intrinsic value of options exercised... | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the options outstanding and exercisable had an intrinsic value of $ 0.5 million and $ 0.3 million, respectively. There were no options with an exercise price greater than the market price on December 31, 2024 to ex... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
The Company has an authorized employee stock purchase plan (the “ESPP”) that would enable employees to contribute up to 15 % of their base compensation toward the purchase of the Company’s common stock at 85 % of its market value on the first or last day of each offering period. The ESPP was not implemented through Dec... | text | 15 | percentItemType | text: <entity> 15 </entity> <entity type> percentItemType </entity type> <context> The Company has an authorized employee stock purchase plan (the “ESPP”) that would enable employees to contribute up to 15 % of their base compensation toward the purchase of the Company’s common stock at 85 % of its market value on the ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate |
The Company has an authorized employee stock purchase plan (the “ESPP”) that would enable employees to contribute up to 15 % of their base compensation toward the purchase of the Company’s common stock at 85 % of its market value on the first or last day of each offering period. The ESPP was not implemented through Dec... | text | 85 | percentItemType | text: <entity> 85 </entity> <entity type> percentItemType </entity type> <context> The Company has an authorized employee stock purchase plan (the “ESPP”) that would enable employees to contribute up to 15 % of their base compensation toward the purchase of the Company’s common stock at 85 % of its market value on the ... | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent |
Depreciation expense for the years ended December 31, 2024 and 2023 totaled approximately $ 3.1 million and $ 3.2 million, respectively. For the year ended December 31, 2024, $ 0.4 million and $ 2.7 million was included in selling, general and administrative expenses and R&D expenses, respectively, in the consolidated ... | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2024 and 2023 totaled approximately $ 3.1 million and $ 3.2 million, respectively. For the year ended December 31, 2024, $ 0.4 million and $ 2.7 million was included in selling, gen... | us-gaap:Depreciation |
Depreciation expense for the years ended December 31, 2024 and 2023 totaled approximately $ 3.1 million and $ 3.2 million, respectively. For the year ended December 31, 2024, $ 0.4 million and $ 2.7 million was included in selling, general and administrative expenses and R&D expenses, respectively, in the consolidated ... | text | 3.2 | monetaryItemType | text: <entity> 3.2 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2024 and 2023 totaled approximately $ 3.1 million and $ 3.2 million, respectively. For the year ended December 31, 2024, $ 0.4 million and $ 2.7 million was included in selling, gen... | us-gaap:Depreciation |
Depreciation expense for the years ended December 31, 2024 and 2023 totaled approximately $ 3.1 million and $ 3.2 million, respectively. For the year ended December 31, 2024, $ 0.4 million and $ 2.7 million was included in selling, general and administrative expenses and R&D expenses, respectively, in the consolidated ... | text | 0.4 | monetaryItemType | text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2024 and 2023 totaled approximately $ 3.1 million and $ 3.2 million, respectively. For the year ended December 31, 2024, $ 0.4 million and $ 2.7 million was included in selling, gen... | us-gaap:Depreciation |
Depreciation expense for the years ended December 31, 2024 and 2023 totaled approximately $ 3.1 million and $ 3.2 million, respectively. For the year ended December 31, 2024, $ 0.4 million and $ 2.7 million was included in selling, general and administrative expenses and R&D expenses, respectively, in the consolidated ... | text | 2.7 | monetaryItemType | text: <entity> 2.7 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2024 and 2023 totaled approximately $ 3.1 million and $ 3.2 million, respectively. For the year ended December 31, 2024, $ 0.4 million and $ 2.7 million was included in selling, gen... | us-gaap:Depreciation |
$ 0.6 million, $ 1.7 million, and $ 0.9 million was included in selling, general and administrative expenses, R&D expenses and exit and termination costs, respectively, in the co | text | 0.6 | monetaryItemType | text: <entity> 0.6 </entity> <entity type> monetaryItemType </entity type> <context> $ 0.6 million, $ 1.7 million, and $ 0.9 million was included in selling, general and administrative expenses, R&D expenses and exit and termination costs, respectively, in the co </context> | us-gaap:Depreciation |
$ 0.6 million, $ 1.7 million, and $ 0.9 million was included in selling, general and administrative expenses, R&D expenses and exit and termination costs, respectively, in the co | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> $ 0.6 million, $ 1.7 million, and $ 0.9 million was included in selling, general and administrative expenses, R&D expenses and exit and termination costs, respectively, in the co </context> | us-gaap:Depreciation |
$ 0.6 million, $ 1.7 million, and $ 0.9 million was included in selling, general and administrative expenses, R&D expenses and exit and termination costs, respectively, in the co | text | 0.9 | monetaryItemType | text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> $ 0.6 million, $ 1.7 million, and $ 0.9 million was included in selling, general and administrative expenses, R&D expenses and exit and termination costs, respectively, in the co </context> | us-gaap:Depreciation |
The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remaining $ 335.7 million has an indefinite carryforward period. The Company had state net... | text | 346.2 | monetaryItemType | text: <entity> 346.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the rem... | us-gaap:OperatingLossCarryforwards |
The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remaining $ 335.7 million has an indefinite carryforward period. The Company had state net... | text | 297.9 | monetaryItemType | text: <entity> 297.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the rem... | us-gaap:OperatingLossCarryforwards |
The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remaining $ 335.7 million has an indefinite carryforward period. The Company had state net... | text | 10.5 | monetaryItemType | text: <entity> 10.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the rema... | us-gaap:OperatingLossCarryforwards |
The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remaining $ 335.7 million has an indefinite carryforward period. The Company had state net... | text | 335.7 | monetaryItemType | text: <entity> 335.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the rem... | us-gaap:OperatingLossCarryforwards |
The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remaining $ 335.7 million has an indefinite carryforward period. The Company had state net... | text | 12.5 | monetaryItemType | text: <entity> 12.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the rema... | us-gaap:OperatingLossCarryforwards |
The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remaining $ 335.7 million has an indefinite carryforward period. The Company had state net... | text | 4.7 | monetaryItemType | text: <entity> 4.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remai... | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration |
The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remaining $ 335.7 million has an indefinite carryforward period. The Company had state net... | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remai... | us-gaap:OtherOperatingIncomeExpenseNet |
The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remaining $ 335.7 million has an indefinite carryforward period. The Company had state net... | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company had federal net operating loss carryforwards of $ 346.2 million and $ 297.9 million at December 31, 2024 and 2023, respectively. At December 31, 2024, $ 10.5 million of this amount will begin to expire in 2036 and the remai... | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration |
During the quarter ended March 31, 2024, in connection with our operations in Cedar Park, Texas, the Company entered into an agreement with the Cedar Park Economic Development Corporation (“EDC”) that superseded prior agreements, whereby the Company would receive cash grants up to $ 1.1 million from the EDC at various ... | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> During the quarter ended March 31, 2024, in connection with our operations in Cedar Park, Texas, the Company entered into an agreement with the Cedar Park Economic Development Corporation (“EDC”) that superseded prior agreements, where... | us-gaap:GovernmentAssistanceAwardAmount |
fore specific measurement dates and maintained throughout the term of the agreement, which expires effective December 31, 2029. The Company has received payments to date of $ 0.4 million which are refundable as applicable performance requirements were not met and are included within accrued expenses and other current l... | text | 0.4 | monetaryItemType | text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> fore specific measurement dates and maintained throughout the term of the agreement, which expires effective December 31, 2029. The Company has received payments to date of $ 0.4 million which are refundable as applicable performance r... | us-gaap:GovernmentAssistanceLiabilityNoncurrent |
On December 15, 2023, Zurn Holdings, Inc. (“Holdings”) sold all of the equity interests of its direct subsidiary Zurn Industries, LLC (“Zurn Industries”), together with Zurn Industries’ direct and indirect subsidiaries that primarily held asbestos liabilities, certain assets and cash, in a stock sale transaction to an ... | text | 11.4 | monetaryItemType | text: <entity> 11.4 </entity> <entity type> monetaryItemType </entity type> <context> On December 15, 2023, Zurn Holdings, Inc. (“Holdings”) sold all of the equity interests of its direct subsidiary Zurn Industries, LLC (“Zurn Industries”), together with Zurn Industries’ direct and indirect subsidiaries that primarily ... | us-gaap:GainLossOnSaleOfBusiness |
Inventories are comprised of material, direct labor and manufacturing overhead, and are stated at the lower of cost or market. Market is determined based on estimated net realizable values. The percentage of the Company’s total inventories valued using the "last-in, first-out" (LIFO) method was 94 % and 92 % at Decembe... | text | 94 | percentItemType | text: <entity> 94 </entity> <entity type> percentItemType </entity type> <context> Inventories are comprised of material, direct labor and manufacturing overhead, and are stated at the lower of cost or market. Market is determined based on estimated net realizable values. The percentage of the Company’s total inventori... | us-gaap:PercentageOfLIFOInventory |
Inventories are comprised of material, direct labor and manufacturing overhead, and are stated at the lower of cost or market. Market is determined based on estimated net realizable values. The percentage of the Company’s total inventories valued using the "last-in, first-out" (LIFO) method was 94 % and 92 % at Decembe... | text | 92 | percentItemType | text: <entity> 92 </entity> <entity type> percentItemType </entity type> <context> Inventories are comprised of material, direct labor and manufacturing overhead, and are stated at the lower of cost or market. Market is determined based on estimated net realizable values. The percentage of the Company’s total inventori... | us-gaap:PercentageOfLIFOInventory |
In some cases, the Company has determined a certain portion of inventories are excess or obsolete. In those cases, the Company writes down the value of those inventories to their net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than th... | text | 11.6 | monetaryItemType | text: <entity> 11.6 </entity> <entity type> monetaryItemType </entity type> <context> In some cases, the Company has determined a certain portion of inventories are excess or obsolete. In those cases, the Company writes down the value of those inventories to their net realizable value based upon assumptions about futur... | us-gaap:InventoryWriteDown |
In some cases, the Company has determined a certain portion of inventories are excess or obsolete. In those cases, the Company writes down the value of those inventories to their net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than th... | text | 3.4 | monetaryItemType | text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> In some cases, the Company has determined a certain portion of inventories are excess or obsolete. In those cases, the Company writes down the value of those inventories to their net realizable value based upon assumptions about future... | us-gaap:InventoryWriteDown |
In some cases, the Company has determined a certain portion of inventories are excess or obsolete. In those cases, the Company writes down the value of those inventories to their net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than th... | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> In some cases, the Company has determined a certain portion of inventories are excess or obsolete. In those cases, the Company writes down the value of those inventories to their net realizable value based upon assumptions about future... | us-gaap:InventoryWriteDown |
During the fourth quarter of the year ended December 31, 2024, the Company completed its annual goodwill and intangible asset impairment tests and elected to perform a qualitative assessment. No goodwill impairment charges were recorded during the years ended December 31, 2024, 2023, or 2022. During the year ended Dece... | text | 0.6 | monetaryItemType | text: <entity> 0.6 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of the year ended December 31, 2024, the Company completed its annual goodwill and intangible asset impairment tests and elected to perform a qualitative assessment. No goodwill impairment charges were recorde... | us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill |
The computation for diluted net income per share for the years ended December 31, 2024, 2023, and 2022 excludes 0.2 million, 0.3 million and 0.4 million common shares due to their anti-dilutive effects, respectively. | text | 0.2 | sharesItemType | text: <entity> 0.2 </entity> <entity type> sharesItemType </entity type> <context> The computation for diluted net income per share for the years ended December 31, 2024, 2023, and 2022 excludes 0.2 million, 0.3 million and 0.4 million common shares due to their anti-dilutive effects, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
The computation for diluted net income per share for the years ended December 31, 2024, 2023, and 2022 excludes 0.2 million, 0.3 million and 0.4 million common shares due to their anti-dilutive effects, respectively. | text | 0.3 | sharesItemType | text: <entity> 0.3 </entity> <entity type> sharesItemType </entity type> <context> The computation for diluted net income per share for the years ended December 31, 2024, 2023, and 2022 excludes 0.2 million, 0.3 million and 0.4 million common shares due to their anti-dilutive effects, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
The computation for diluted net income per share for the years ended December 31, 2024, 2023, and 2022 excludes 0.2 million, 0.3 million and 0.4 million common shares due to their anti-dilutive effects, respectively. | text | 0.4 | sharesItemType | text: <entity> 0.4 </entity> <entity type> sharesItemType </entity type> <context> The computation for diluted net income per share for the years ended December 31, 2024, 2023, and 2022 excludes 0.2 million, 0.3 million and 0.4 million common shares due to their anti-dilutive effects, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Assets and liabilities of subsidiaries operating outside of the United States with a functional currency other than the U.S. dollar are translated into U.S. dollars using exchange rates at the end of the respective period. Revenues and expenses of such entities are translated at average exchange rates in effect during ... | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> Assets and liabilities of subsidiaries operating outside of the United States with a functional currency other than the U.S. dollar are translated into U.S. dollars using exchange rates at the end of the respective period. Revenues and... | us-gaap:ForeignCurrencyTransactionGainLossBeforeTax |
Assets and liabilities of subsidiaries operating outside of the United States with a functional currency other than the U.S. dollar are translated into U.S. dollars using exchange rates at the end of the respective period. Revenues and expenses of such entities are translated at average exchange rates in effect during ... | text | 0.9 | monetaryItemType | text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> Assets and liabilities of subsidiaries operating outside of the United States with a functional currency other than the U.S. dollar are translated into U.S. dollars using exchange rates at the end of the respective period. Revenues and... | us-gaap:ForeignCurrencyTransactionGainLossBeforeTax |
Assets and liabilities of subsidiaries operating outside of the United States with a functional currency other than the U.S. dollar are translated into U.S. dollars using exchange rates at the end of the respective period. Revenues and expenses of such entities are translated at average exchange rates in effect during ... | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> Assets and liabilities of subsidiaries operating outside of the United States with a functional currency other than the U.S. dollar are translated into U.S. dollars using exchange rates at the end of the respective period. Revenues and... | us-gaap:ForeignCurrencyTransactionGainLossBeforeTax |
Advertising costs are charged to selling, general and administrative expenses on the consolidated statements of operations as incurred and amounted to $ 18.1 million, $ 18.4 million and $ 12.5 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 18.1 | monetaryItemType | text: <entity> 18.1 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are charged to selling, general and administrative expenses on the consolidated statements of operations as incurred and amounted to $ 18.1 million, $ 18.4 million and $ 12.5 million for the years ended December 31, ... | us-gaap:AdvertisingExpense |
Advertising costs are charged to selling, general and administrative expenses on the consolidated statements of operations as incurred and amounted to $ 18.1 million, $ 18.4 million and $ 12.5 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 18.4 | monetaryItemType | text: <entity> 18.4 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are charged to selling, general and administrative expenses on the consolidated statements of operations as incurred and amounted to $ 18.1 million, $ 18.4 million and $ 12.5 million for the years ended December 31, ... | us-gaap:AdvertisingExpense |
Advertising costs are charged to selling, general and administrative expenses on the consolidated statements of operations as incurred and amounted to $ 18.1 million, $ 18.4 million and $ 12.5 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 12.5 | monetaryItemType | text: <entity> 12.5 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are charged to selling, general and administrative expenses on the consolidated statements of operations as incurred and amounted to $ 18.1 million, $ 18.4 million and $ 12.5 million for the years ended December 31, ... | us-gaap:AdvertisingExpense |
On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Company's existing product portfolio. The purchase price includes $ 1,411.9 million of Zurn... | text | 1457.8 | monetaryItemType | text: <entity> 1457.8 </entity> <entity type> monetaryItemType </entity type> <context> On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Com... | us-gaap:BusinessCombinationConsiderationTransferred1 |
On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Company's existing product portfolio. The purchase price includes $ 1,411.9 million of Zurn... | text | 1411.9 | monetaryItemType | text: <entity> 1411.9 </entity> <entity type> monetaryItemType </entity type> <context> On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Com... | us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable |
On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Company's existing product portfolio. The purchase price includes $ 1,411.9 million of Zurn... | text | 27.48 | perShareItemType | text: <entity> 27.48 </entity> <entity type> perShareItemType </entity type> <context> On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Comp... | us-gaap:BusinessAcquisitionSharePrice |
On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Company's existing product portfolio. The purchase price includes $ 1,411.9 million of Zurn... | text | 45.9 | monetaryItemType | text: <entity> 45.9 </entity> <entity type> monetaryItemType </entity type> <context> On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Compa... | us-gaap:PaymentsToAcquireBusinessesGross |
On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Company's existing product portfolio. The purchase price includes $ 1,411.9 million of Zurn... | text | 51564524 | sharesItemType | text: <entity> 51564524 </entity> <entity type> sharesItemType </entity type> <context> On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Com... | us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued |
On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Company's existing product portfolio. The purchase price includes $ 1,411.9 million of Zurn... | text | 33.7 | monetaryItemType | text: <entity> 33.7 </entity> <entity type> monetaryItemType </entity type> <context> On July 1, 2022, the Company completed the Elkay Merger for a purchase price (after final purchase price adjustments) of $ 1,457.8 million. Elkay, a market leader of drinking water solutions and commercial sinks, complements the Compa... | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
The following unaudited supplemental pro forma financial information presents the financial results from continuing operations for the year ended December 31, 2022 as if the Elkay Merger had occurred on January 1, 2022. The pro forma financial information includes, where applicable, adjustments for: (i) additional amor... | text | 33.7 | monetaryItemType | text: <entity> 33.7 </entity> <entity type> monetaryItemType </entity type> <context> The following unaudited supplemental pro forma financial information presents the financial results from continuing operations for the year ended December 31, 2022 as if the Elkay Merger had occurred on January 1, 2022. The pro forma ... | us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.